C Berger
Impact in
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Pregnancy and preeclampsia studies 6
-
- Dermatologic Treatments and Research 4
- Co-authors
- Marc VandemeulebroeckeSimon TravisPeter HigginsWalter ReinischGerard BruinSteve LewitzkyArthur P. BertolinoMarco Londei
In The Last Decade
C Berger
52 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Immunology 855
- Hematology 244
- Dermatology 170
- Rheumatology 252
- Genetics 463
Countries citing papers authored by C Berger
This map shows the geographic impact of C Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Berger more than expected).
Fields of papers citing papers by C Berger
This network shows the impact of papers produced by C Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Berger. The network helps show where C Berger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 3 | |
| 3 | 2018 | 4 | |
| 4 | 2015 | 52 | |
| 5 | 2015 | 26 | |
| 6 | 2013 | 42 | |
| 7 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Hit paper breakdown → | 2012 | 1156 |
| 8 | [Venous leg ulcers: no improvement of wound healing with 685-nm low level laser therapy. Randomised, placebo-controlled, double-blind study]. | 2005 | 8 |
| 9 | Ulcus cruris venosum: Keine Verbesserung der Wundheilung durch Anwendung eines 685-nm-Low-Level-Lasers: Randomisierte, placebokontrollierte, doppelblinde Studie | 2005 | 4 |
| 10 | 2005 | 122 | |
| 11 | 2004 | 9 | |
| 12 | 2003 | 31 | |
| 13 | 2002 | 20 | |
| 14 | 2001 | 1 | |
| 15 | 1998 | 3 | |
| 16 | 1996 | 1 | |
| 17 | 1993 | 13 | |
| 18 | [Spontaneous rupture of the membranes before 28 weeks of amenorrhea. Obstetrical and perinatal outcome. Apropos of 28 cases]. | 1991 | 2 |
| 19 | 1989 | 3 | |
| 20 | [Doppler examination of the umbilical and cerebral arterial circulation of the fetus]. | 1987 | 10 |
About C Berger
C Berger is a scholar working on Obstetrics and Gynecology, Dermatology, Applied Microbiology and Biotechnology, Biochemistry and Critical Care and Intensive Care Medicine, having authored 57 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (6 papers), Adipose Tissue and Metabolism (6 papers), Laser Applications in Dentistry and Medicine (4 papers), Dermatologic Treatments and Research (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Neuropeptides and Animal Physiology (3 papers), Chemical Synthesis and Analysis (3 papers) and Inflammatory Bowel Disease (3 papers). The work is most often cited by research in Immunology (855 citations), Hematology (244 citations), Dermatology (170 citations), Rheumatology (252 citations) and Genetics (463 citations). C Berger has collaborated with scholars based in Germany, France and Austria. Frequent co-authors include Marc Vandemeulebroecke, Simon Travis, Peter Higgins, Walter Reinisch, Gerard Bruin, Steve Lewitzky, Arthur P. Bertolino, Marco Londei, Stephan Bek and Marek Karczewski. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, International Journal of Molecular Sciences, Clinical Neurophysiology and Molecular & Cellular Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.